Although the introduction of tumor necrosis factor alpha inhibitors (TNF-i) for the treatment of RA represents a significant advance in this area, the therapy is associated with an increase in the incidence of active TB disease among the population of RA patients [3]. This evidence concerns the gene TNF and rheumatoid arthritis.